Dr. Neil Paulvin joins me again today for the second part of the two-part series. Last week, in Part 1, he shared general tips for longevity. In Part 2 today, he discusses many new longevity tests, including the full-body MRI, DEXA scans, Galleri testing, Cleerly, EndoPAT, VO2 Max, and biological age testing.
Listen to the Episode
Or listen and subscribe for free in your favorite podcast app!
Dr. Neil Paulvin’s Bio:
Dr. Neil Paulvin has certifications in Family Medicine, Osteopathic Manipulation, and Anti-Aging and Regenerative Medicine.
His practice in Manhattan combines traditional and alternative medicine to help patients live a healthy lifestyle and perform at their best. As a leading expert in biohacking and human optimization, Dr.Paulvin is recognized for his exceptional work applying a hyper-personal approach to help his patients, including Fortune 500 executives, Olympic athletes, and A-list celebrities, optimize their health, perform better under pressure, recover faster and move beyond the baseline.
In this episode:
- A breakdown of the Prenuvo MRI Full Body Scan (1:52)
- What the Cleerly test does (3:10)
- The benefits of the DEXA scan (6:49)
- Dr.Paulvin explains Galleri cancer screening (8:50)
- What circulating tumor cell testing measures (11:13)
- Dr.Paulvin discusses EndoPAT testing (11:30)
- How V02 Max testing gets done (14:32)
- Dr.Paulvin talks about biological age testing (19:25)
- Dr.Paulvin discusses the health supplements and biohacking tools he likes to use (23:54)
Links and Resources:
Use code COQ10 to get 10% off COQ10
Use code OMEGA3S to get 10% off OMEGA3S
Follow Your Longevity Blueprint
On Instagram | Facebook | Twitter | YouTube | LinkedIn
Get your copy of the Your Longevity Blueprint book and claim your bonuses here
Find Dr. Stephanie Gray and Your Longevity Blueprint online
Follow Dr. Stephanie Gray
on Facebook | Instagram | Youtube | Twitter | LinkedIn
Integrative Health and Hormone Clinic
Podcast production by Team Podcast
Guest Social Media Links:
You must be logged in to post a comment.